Page last updated: 2024-12-10

ribose-1,5-bisphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ribose-1,5-bisphosphate: RN given for (D)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-ribose 1,5-bisphosphate : A ribose bisphosphate that consists of D-ribose having two monophosphate groups at the 1- and 5-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3036640
CHEBI ID17994
SCHEMBL ID1332683
MeSH IDM0144303

Synonyms (13)

Synonym
ribose-1,5-diphosphate
d-ribofuranose, 1,5-bis(dihydrogen phosphate)
CHEBI:17994
1,5-di-o-phosphono-d-ribofuranose
d-ribofuranose 1,5-bis(dihydrogen phosphate)
d-ribose 1,5-bisphosphate
ribose-1,5-bisphosphate
[(3r,4s,5r)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl] dihydrogen phosphate
SCHEMBL1332683
Q27102751
DTXSID101252223
CS-0082409
HY-114327
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ribose bisphosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Calvin cycle319
PCO cycle824

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's4 (25.00)18.2507
2000's8 (50.00)29.6817
2010's3 (18.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.86 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]